The Jurkat cell line is an immortal T-lymphocyte cell line originally obtained from peripheral blood of a boy with T-cell leukemia. The Jurkat cell line has been used to study multiple events in T cell biology. Creative Biolabs focuses on the development of novel CAR/TCR-based cell therapies and committed providing human Jurkat cell products.
Control the quality of cells our top priority. Whether you are an academic researcher, an immunologist or a drug researcher, your research depends on the purity, viability and function of our cells. We take it seriously.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.LEARN MORE
End-to-end CAR Hybrid TCR (CHyT)-T Cell Therapy Development Services: A novel solution to engineer T cell to be a promising cellular therapy with the complete TCR without HLA dependence.LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.LEARN MORE